JLJameela Lokhandwala

Jameela Lokhandwala

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jameela Lokhandwala has a total of 24 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    RNA-Bound MYBL2 Engages the Oncogenic Transcription Factors MAFG and FRA1 to Promote Melanoma Progression

    by Kaizhen Wang, Xiaonan Xu, Zulaida Soto-Vargas, Shiun Chang, Nicol Mecozzi, Olga Vera, Nhan Phan, Rachel P. Kogan, Manon Chadourne, Jameela Lokhandwala, et al.

    Non-mutational mechanisms, including copy number alterations and transcription factor dysregulation, are critical drivers of melanoma progression. Here, we identify the transcription factor MYBL2 as a key oncogenic driver located on frequently amplified chromosome 20q. MYBL2 overexpression promoted transformation and correlated with poor survival, yet paradoxically, the transactivation function of MYBL2 was dispensable for oncogenic activity. Instead, MYBL2 acquired a non-canonical RNA-binding function enabled by the melanoma-associated RNA landscape. Through these RNA interactions, MYBL2 reshaped the chromatin landscape toward an AP-1-permissive state and promoted chromatin association of the oncogenic transcription factors MAFG and FRA1, indirectly reprogramming tumor-promoting gene networks that predict poor outcomes across multiple cancers. Importantly, a decoy RNA that disrupts the MYBL2-RNA interaction impaired MYBL2 association with MAFG and FRA1 and suppressed melanoma cell growth. These findings establish MYBL2 as an RNA-binding-dependent, 20q gain-associated driver that promotes melanoma progression through chromatin and transcriptional network remodeling.

  • Open Access

    Ancestral protein reconstruction reveals the mechanism of substrate specificity in FN3K-mediated deglycation

    by Jenet K. Matlack, Robert E. Miner, Jameela Lokhandwala, Jennifer M. Binning

    Protein glycation is a detrimental byproduct of living cells’ reliance on carbohydrate metabolism, and nearly all organisms encode kinases that facilitate the removal of early glycation products. In humans, these repair functions are performed by Fructosamine-3 kinase (FN3K) and Ketosamine-3 kinase (KT3K) enzymes which share conserved catalytic mechanisms but differ in substrate specificity. Recent structural studies defined key active site residues required for FN3K activity on a model substrate, yet the molecular basis for differential substrate recognition by FN3K and KT3K remains unresolved. Here, we integrate phylogenetic analysis, ancestral protein reconstruction (APR), and mutational biochemistry to to elucidate how substrate specificity evolved within the fructosamine-3 kinase family. We show that conserved substrate-binding residues are required for the phosphorylation of both fructosamines and ketosamines, but do not contribute to substrate specificity. Using APR, we resurrected four ancestral fructosamine kinases that recapitulate the distinct substrate preferences of FN3K and KT3K despite differing by only 12 amino acids. Through mutational studies and structural analysis, we show that substrate specificity is modulated by an evolutionarily tuned allosteric network that enables long-range intramolecular communication. These insights provide a new mechanistic framework for understanding FN3K substrate selection and open avenues for rational design of FN3K-selective therapeutics targeting protein glycation in metabolic disease and aging.

  • Open Access

    Disrupting FKF1 homodimerization increases FT transcript levels in the evening by enhancing CO stabilization

    by Sung Won Cho, Jameela Lokhandwala, Jun Sang Park, Hye Won Kang, Mingi Choi, Hong-Quan Yang, Takato Imaizumi, Brian D. Zoltowski, Young Hun Song

    Key message: FKF1 dimerization is crucial for proper FT levels to fine-tune flowering time. Attenuating FKF1 homodimerization increased CO abundance by enhancing its COP1 binding, thereby accelerating flowering under long days. In Arabidopsis (Arabidopsis thaliana), the blue-light photoreceptor FKF1 (FLAVIN-BINDING, KELCH REPEAT, F-BOX 1) plays a key role in inducing the expression of FLOWERING LOCUS T (FT), encoding the main florigenic signal in plants, in the late afternoon under long-day conditions (LDs) by forming dimers with FT regulators. Although structural studies have unveiled a variant of FKF1 (FKF1 I160R) that disrupts homodimer formation in vitro, the mechanism by which disrupted FKF1 homodimer formation regulates flowering time remains elusive. In this study, we determined that the attenuation of FKF1 homodimer formation enhances FT expression in the evening by promoting the increased stability of CONSTANS (CO), a primary activator of FT, in the afternoon, thereby contributing to early flowering. In contrast to wild-type FKF1, introducing the FKF1 I160R variant into the fkf1 mutant led to increased FT expression under LDs. In addition, the FKF1 I160R variant exhibited diminished dimerization with FKF1, while its interaction with GIGANTEA (GI), a modulator of FKF1 function, was enhanced under LDs. Furthermore, the FKF1 I160R variant increased the level of CO in the afternoon under LDs by enhancing its binding to COP1, an E3 ubiquitin ligase responsible for CO degradation. These findings suggest that the regulation of FKF1 homodimerization and heterodimerization allows plants to finely adjust FT expression levels around dusk by modulating its interactions with GI and COP1.